NCT03486275 is a NA clinical trial of Hygie in CONTINUING MEDICAL EDUCATION, sponsored by Hygie.

Who is sponsoring NCT03486275?

NCT03486275 is sponsored by Hygie.

What drugs are being tested in NCT03486275?

Interventions in NCT03486275: Hygie, Source articles.

What condition does NCT03486275 study?

NCT03486275 studies CONTINUING MEDICAL EDUCATION.

Is NCT03486275 still recruiting?

NCT03486275 is currently completed. Last updated 10 April 2018.

Last reviewed 2018-04-10 · How we verify

NCT03486275

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Development and Evaluation of Hygie, a New Serious Game for Continuing Medical Education of General Practitioners

Completed NA Last updated 10 April 2018

What this trial tests

NA trial testing Hygie in CONTINUING MEDICAL EDUCATION in 3,398 participants. Completed in 6 September 2017.

Timeline

31 May 2017

Primary endpoint
6 September 2017

6 September 2017

Quick facts

Lead sponsor	Hygie
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	other
Enrollment	3,398
Start date	31 May 2017
Primary completion	6 September 2017
Estimated completion	6 September 2017
Sites	1 location across France

Drugs / interventions tested

Hygie
Source articles

Conditions studied

CONTINUING MEDICAL EDUCATION — all drugs for CONTINUING MEDICAL EDUCATION →

Sponsor

Hygie — full company profile →

Who can join

Eligibility, any sex, with CONTINUING MEDICAL EDUCATION. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

We produced a prototype video game called Hygie on the 5 most common reasons of consultation in general practice using 9 articles from independent journals based on evidence (reviews by Prescrire and Minerva). We then carried out a randomized trial comparing the learning provided by a week of access to the game versus source articles, in a population of clinical supervisors (CS) from 13 French departments of general practice.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Development and Evaluation of a New Serious Game for Continuing Medical Education of General Practitioners (Hygie): Double-Blinded Randomized Controlled Trial.
Jaunay LB, Zerr P, Peguin L, Renouard L, et al · · 2019 · cited 8× · PMID 31746775 · DOI 10.2196/12669

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03486275 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hygie
Last refreshed: 10 April 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03486275.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing